BIIB021
- Generic Name
- BIIB021
- Drug Type
- Small Molecule
- Chemical Formula
- C14H15ClN6O
- CAS Number
- 848695-25-0
- Unique Ingredient Identifier
- 851B9FQ7Q0
- Background
BIIB021 has been investigated for the treatment of Tumors and Lymphoma.
Effect of Food and Antacid on BIIB021 With Advanced Solid Tumors
Phase 1
Completed
- Conditions
- Advanced Solid Tumors
- Interventions
- Drug: BIIB0121 and Antacid
- First Posted Date
- 2009-11-20
- Last Posted Date
- 2013-09-16
- Lead Sponsor
- Biogen
- Target Recruit Count
- 20
- Registration Number
- NCT01017198
- Locations
- ๐บ๐ธ
Reseach Facility, San Antonio, Texas, United States
Hormone Receptor Positive Metastatic Breast Cancer (HR+ mBC) BIIB021 Plus Aromasin Schedule Finding
- First Posted Date
- 2009-10-29
- Last Posted Date
- 2015-10-02
- Lead Sponsor
- Biogen
- Target Recruit Count
- 54
- Registration Number
- NCT01004081
- Locations
- ๐ท๐บ
Research Site, St. Petersburg, Russian Federation
Once or Twice Daily Administration of BIIB021 to Subjects With Advanced Solid Tumors
- First Posted Date
- 2008-02-20
- Last Posted Date
- 2016-12-29
- Lead Sponsor
- Biogen
- Target Recruit Count
- 68
- Registration Number
- NCT00618735
- Locations
- ๐บ๐ธ
Research Site, San Antonio, Texas, United States
An Open-Label, 18FDG-PET Pharmacodynamic Assessment of the Effect of BIIB021 in Subjects With Gastrointestinal Stromal Tumors (GIST)
- First Posted Date
- 2008-02-20
- Last Posted Date
- 2015-10-02
- Lead Sponsor
- Biogen
- Target Recruit Count
- 20
- Registration Number
- NCT00618319
- Locations
- ๐บ๐ธ
Research Site, Santa Monica, California, United States
๐บ๐ธReseach Facility, San Antonio, Texas, United States
CNF2024 (BIIB021) HER2- (QD) HER2+ (BIW w/Herceptin) PK/PD Study
- First Posted Date
- 2006-12-18
- Last Posted Date
- 2012-06-08
- Lead Sponsor
- Biogen
- Target Recruit Count
- 34
- Registration Number
- NCT00412412
- Locations
- ๐บ๐ธ
Research Site, New York, New York, United States
๐บ๐ธResearch site, Houston, Texas, United States
Study of Oral CNF2024 (BIIB021) in Advanced Solid Tumors
- First Posted Date
- 2006-06-27
- Last Posted Date
- 2009-07-14
- Lead Sponsor
- Biogen
- Target Recruit Count
- 70
- Registration Number
- NCT00345189
- Locations
- ๐ฌ๐ง
Research site, Sutton, Surrey, United Kingdom
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
ยฉ Copyright 2025. All Rights Reserved by MedPath